Stage-specific incidence and survival of breast cancer in Norway: The implications of changes in coding and classification practice

Breast

Volumn 38, Issue , 2018, Pages 107-113

  Larsen, Inger Kristin ^a   Myklebust, Tor Åge ^a,b   Johannesen, Tom Børge ^a   Møller, Bjørn ^a   Hofvind, Solveig ^a,c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b Møre and Romsdal Hospital Trust   (Norway)

^c OSLO METROPOLITAN UNIVERSITY   (Norway)

Author keywords

Breast cancer; Incidence; Stage; Survival

Indexed keywords

ADULT; AGE; AGE SPECIFIC SURVIVAL; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CODING; CONTROLLED STUDY; FEMALE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; NORWAY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELATIVE SURVIVAL; SCREENING; STAGE SPECIFIC INCIDENCE; TREND STUDY; BREAST TUMOR; CLASSIFICATION; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; HEALTH CARE PLANNING; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; REGISTER; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTH PLAN IMPLEMENTATION; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; NORWAY; REGISTRIES;

EID: 85040019816     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2017.12.001     Document Type: Article

References (24)

1. Cancer Registry of Norway, Cancer in Norway 2016-Cancer incidence, mortality, survival and prevalence in Norway. 2017, Cancer Registry of Norway, Oslo.
2. Larsen, I.K., Smastuen, M., Johannesen, T.B., Langmark, F., Parkin, D.M., Bray, F., et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer Oxf Engl 1990 45:7 (2009), 1218–1231.
3. Mammografiprogrammet - Resultater fra prosessindikatorer, 2006-2013/14, 2015, Cancer Registry of Norway, Oslo.
4. Hofvind, S., Geller, B., Vacek, P.M., Thoresen, S., Skaane, P., Using the European guidelines to evaluate the Norwegian breast cancer screening program. Eur J Epidemiol 22:7 (2007), 447–455.
5. Hofvind, S.T.K., Mangerud, G., Ertzaas, A.K., The Norwegian Breast Cancer Screening Program, 1996–2016: celebrating 20 years of organised mammographic screening. Special issue in Cancer in Norway 2016-Cancer incidence, mortality, survival and prevalence in Norway. 2017, Cancer Registry of Norway, Oslo.
6. Manual for staging of cancer. Beahrs, O.H., Myers, M.H., (eds.) American Joint committee on cancer, second ed., 1983, J.B. Lippincott Company, Philadelphia 250 pp.
7. Manual for staging of cancer. Beahrs, O.H., Henson, D.E., Hutter, R.V.P., Kennedy, B.J., (eds.) American Joint committee on cancer, fourth ed., 1992, J.B. Lippincott Company, Philadelphia 285 pp.
8. Greene, F.L., Page, D.L., Fleming, I.D., Fritz, A.G., Balch, C.M., Haller, D.G., et al. (eds.) AJCC cancer staging manual, sixth ed., 2002, Springer-Verlag, New York 200 pp.
9. Walters, S., Maringe, C., Butler, J., Rachet, B., Barrett-Lee, P., Bergh, J., et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer 108:5 (2013), 1195–1208.
10. Walters, S., Maringe, C., Butler, J., Brierley, J.D., Rachet, B., Coleman, M.P., Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer 132:3 (2013), 676–685.
11. Segi, M., Cancer mortality for selected sites in 24 countries (1950-1957). 1960, Tohoku University of Public Health, Sendai.
12. Doll, R., Payne, P., Watherhouse, J., Cancer incidence in five continents. Table 38, page 217–219, 1966, UICC, Geneva.
13. Perme, M.P., Stare, J., Esteve, J., On estimation in relative survival. Biometrics 68:1 (2012), 113–120.
14. Corazziari, I., Quinn, M., Capocaccia, R., Standard cancer patient population for age standardising survival ratios. Eur J Cancer Oxf Engl 1990 40:15 (2004), 2307–2316.
15. Kim, H.J., Fay, M.P., Feuer, E.J., Midthune, D.N., Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:3 (2000), 335–351.
16. Andersson, I., Ikeda, D.M., Zackrisson, S., Ruschin, M., Svahn, T., Timberg, P., et al. Breast tomosynthesis and digital mammography: a comparison of breast cancer visibility and BIRADS classification in a population of cancers with subtle mammographic findings. Eur Radiol 18:12 (2008), 2817–2825.
17. Kuhl, C.K., MRI of breast tumors. Eur Radiol 10:1 (2000), 46–58.
18. Skaane, P., The additional value of US to mammography in the diagnosis of breast cancer. A prospective study. Acta Radiol Stockholm Sweden 1987 40:5 (1999), 486–490.
19. Kalager, M., Haldorsen, T., Bretthauer, M., Hoff, G., Thoresen, S.O., Adami, H.O., Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res BCR, 11(4), 2009, R44.
20. Hofvind, S., Sorum, R., Thoresen, S., Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program. Acta Oncol Stockholm Sweden 47:2 (2008), 225–231.
21. Hofvind, S., Lee, C.I., Elmore, J.G., Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program. Breast Cancer Res Treat 135:1 (2012), 291–299.
22. Sterne, J.A., White, I.R., Carlin, J.B., Spratt, M., Royston, P., Kenward, M.G., et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ Clin Res Ed, 338, 2009 b2393.
23. Nilssen, Y., Strand, T.E., Fjellbirkeland, L., Bartnes, K., Moller, B., Lung cancer survival in Norway, 1997-2011: from nihilism to optimism. Eur Respir J 47:1 (2016), 275–287.
24. Asli, L.M., Johannesen, T.B., Myklebust, T.A., Moller, B., Eriksen, M.T., Guren, M.G., Preoperative chemoradiotherapy for rectal cancer and impact on outcomes - a population-based study. Radiother Oncol J Eur Soc Ther Radiol Oncol 123:3 (2017), 446–453.